Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 76.3 Billion JPY | 33.3% |
| 2022 | 57.24 Billion JPY | 45.61% |
| 2021 | 39.31 Billion JPY | 6.33% |
| 2020 | 36.97 Billion JPY | -5.2% |
| 2019 | 39 Billion JPY | -28.21% |
| 2018 | 54.32 Billion JPY | -5.69% |
| 2017 | 57.6 Billion JPY | 2.41% |
| 2016 | 56.25 Billion JPY | 16.61% |
| 2015 | 48.24 Billion JPY | 18.96% |
| 2014 | 40.55 Billion JPY | 1.62% |
| 2013 | 39.9 Billion JPY | 20.95% |
| 2012 | 32.99 Billion JPY | -2.7% |
| 2011 | 33.91 Billion JPY | -12.26% |
| 2010 | 38.64 Billion JPY | -7.76% |
| 2009 | 41.89 Billion JPY | 4.45% |
| 2008 | 40.11 Billion JPY | 5.28% |
| 2007 | 38.1 Billion JPY | 8.08% |
| 2006 | 35.25 Billion JPY | 18.67% |
| 2005 | 29.7 Billion JPY | 21.33% |
| 2004 | 24.48 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 81.66 Billion JPY | 7.03% |
| 2023 Q4 | 76.3 Billion JPY | 6.91% |
| 2023 Q2 | 68.55 Billion JPY | 9.49% |
| 2023 Q1 | 62.61 Billion JPY | 9.39% |
| 2023 Q3 | 71.37 Billion JPY | 4.1% |
| 2023 FY | 76.3 Billion JPY | 33.3% |
| 2022 Q3 | 58.68 Billion JPY | 3.14% |
| 2022 Q2 | 56.89 Billion JPY | 25.65% |
| 2022 Q1 | 45.28 Billion JPY | 15.18% |
| 2022 FY | 57.24 Billion JPY | 45.61% |
| 2022 Q4 | 57.24 Billion JPY | -2.46% |
| 2021 Q4 | 39.31 Billion JPY | 5.21% |
| 2021 Q2 | 36.78 Billion JPY | -1.46% |
| 2021 Q1 | 37.32 Billion JPY | 0.96% |
| 2021 FY | 39.31 Billion JPY | 6.33% |
| 2021 Q3 | 37.36 Billion JPY | 1.58% |
| 2020 Q3 | 35.8 Billion JPY | 1.24% |
| 2020 Q1 | 41.61 Billion JPY | 6.69% |
| 2020 Q2 | 35.36 Billion JPY | -15.01% |
| 2020 FY | 36.97 Billion JPY | -5.2% |
| 2020 Q4 | 36.97 Billion JPY | 3.26% |
| 2019 Q3 | 39.29 Billion JPY | -11.24% |
| 2019 FY | 39 Billion JPY | -28.21% |
| 2019 Q1 | 47.43 Billion JPY | -12.69% |
| 2019 Q2 | 44.26 Billion JPY | -6.67% |
| 2019 Q4 | 39 Billion JPY | -0.74% |
| 2018 FY | 54.32 Billion JPY | -5.69% |
| 2018 Q3 | 57.69 Billion JPY | -7.51% |
| 2018 Q2 | 62.37 Billion JPY | 12.07% |
| 2018 Q1 | 55.65 Billion JPY | -3.39% |
| 2018 Q4 | 54.32 Billion JPY | -5.83% |
| 2017 Q4 | 57.6 Billion JPY | 2.95% |
| 2017 Q3 | 55.95 Billion JPY | 19.22% |
| 2017 Q2 | 46.93 Billion JPY | 0.4% |
| 2017 Q1 | 46.74 Billion JPY | -16.9% |
| 2017 FY | 57.6 Billion JPY | 2.41% |
| 2016 Q1 | 49.59 Billion JPY | 2.8% |
| 2016 Q2 | 55.64 Billion JPY | 12.21% |
| 2016 FY | 56.25 Billion JPY | 16.61% |
| 2016 Q4 | 56.25 Billion JPY | 5.45% |
| 2016 Q3 | 53.34 Billion JPY | -4.13% |
| 2015 Q1 | 41.74 Billion JPY | 2.94% |
| 2015 Q3 | 49.4 Billion JPY | 12.12% |
| 2015 Q2 | 44.06 Billion JPY | 5.55% |
| 2015 FY | 48.24 Billion JPY | 18.96% |
| 2015 Q4 | 48.24 Billion JPY | -2.35% |
| 2014 Q3 | 38.57 Billion JPY | 1.3% |
| 2014 FY | 40.55 Billion JPY | 1.62% |
| 2014 Q4 | 40.55 Billion JPY | 5.12% |
| 2014 Q1 | 35.85 Billion JPY | -10.16% |
| 2014 Q2 | 38.07 Billion JPY | 6.21% |
| 2013 Q3 | 39.75 Billion JPY | 6.12% |
| 2013 Q2 | 37.45 Billion JPY | 20.75% |
| 2013 Q1 | 31.02 Billion JPY | -5.98% |
| 2013 FY | 39.9 Billion JPY | 20.95% |
| 2013 Q4 | 39.9 Billion JPY | 0.39% |
| 2012 Q1 | 32.61 Billion JPY | -3.82% |
| 2012 Q4 | 32.99 Billion JPY | -3.18% |
| 2012 Q3 | 34.07 Billion JPY | -6.18% |
| 2012 Q2 | 36.32 Billion JPY | 11.37% |
| 2012 FY | 32.99 Billion JPY | -2.7% |
| 2011 Q4 | 33.91 Billion JPY | -8.12% |
| 2011 Q3 | 36.9 Billion JPY | -4.1% |
| 2011 Q2 | 38.48 Billion JPY | 2.81% |
| 2011 Q1 | 37.43 Billion JPY | -3.15% |
| 2011 FY | 33.91 Billion JPY | -12.26% |
| 2010 FY | 38.64 Billion JPY | -7.76% |
| 2010 Q1 | 40.05 Billion JPY | -4.4% |
| 2010 Q2 | 41.96 Billion JPY | 4.77% |
| 2010 Q3 | 41.33 Billion JPY | -1.5% |
| 2010 Q4 | 38.64 Billion JPY | -6.5% |
| 2009 Q4 | 41.89 Billion JPY | -1.17% |
| 2009 FY | 41.89 Billion JPY | 4.45% |
| 2009 Q3 | 42.39 Billion JPY | 8.26% |
| 2009 Q2 | 39.16 Billion JPY | 0.0% |
| 2008 FY | 40.11 Billion JPY | 5.28% |
| 2008 Q4 | 40.11 Billion JPY | 0.12% |
| 2008 Q3 | 40.06 Billion JPY | 0.0% |
| 2007 FY | 38.1 Billion JPY | 8.08% |
| 2006 FY | 35.25 Billion JPY | 18.67% |
| 2005 FY | 29.7 Billion JPY | 21.33% |
| 2004 FY | 24.48 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| DNA Chip Research Inc. | 982.47 Million JPY | -7666.316% |
| Cosmo Bio Company,Limited | 10.87 Billion JPY | -601.824% |
| H.U. Group Holdings, Inc. | 295.35 Billion JPY | 74.166% |
| FALCO HOLDINGS Co., Ltd. | 36.42 Billion JPY | -109.478% |
| BML, Inc. | 170.99 Billion JPY | 55.376% |
| Human Metabolome Technologies, Inc. | 2.6 Billion JPY | -2830.872% |
| Precision System Science Co., Ltd. | 6.39 Billion JPY | -1092.87% |